Application 065394
- Type
- ANDA
- Sponsor
- ACTAVIS MID ATLANTIC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | GRISEOFULVIN | GRISEOFULVIN, MICROSIZE | SUSPENSION;ORAL | 125MG/5ML | No | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0472-0013 | Griseofulvin | Griseofulvin | Actavis Pharma, Inc. | ANDA | Current |
| 0472-0013 | Griseofulvin | Griseofulvin | Actavis Pharma, Inc. | ANDA | Current |
| 0472-0013 | Griseofulvin | Griseofulvin | Actavis Pharma, Inc. | ANDA | Current |
| 0472-0013 | Griseofulvin | Griseofulvin | Actavis Pharma, Inc. | ANDA | Current |
| 42254-306 | Griseofulviin (microsize) | Griseofulvin (microsize) | Rebel Distributors Corp | ANDA | Current |